Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease

Patients with osteoporosis and chronic kidney disease (CKD) are at increased risk of fracture and associated negative outcomes, including increased mortality. The present post hoc analysis of two randomized, multicenter, phase 3 clinical trials—Fracture Study in Postmenopausal Women with Osteoporosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Paul D, Adachi, Jonathan D, Albergaria, Ben‐Hur, Cheung, Angela M, Chines, Arkadi A, Gielen, Evelien, Langdahl, Bente L, Miyauchi, Akimitsu, Oates, Mary, Reid, Ian R, Santiago, Norma Ruiz, Vanderkelen, Mark, Wang, Zhenxun, Yu, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544335/
https://www.ncbi.nlm.nih.gov/pubmed/35466448
http://dx.doi.org/10.1002/jbmr.4563

Ejemplares similares

Ejemplares similares